Oxford BioDynamics (LON:OBD) Trading Down 22.7% – Should You Sell?

Shares of Oxford BioDynamics Plc (LON:OBD) dropped 22.7% during mid-day trading on Wednesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.70 ($0.02). Approximately 4,144,623 shares traded hands during mid-day trading, an increase of 124% from the average daily volume of 1,847,190 shares. The stock had previously closed at GBX 2.20 ($0.03).

Oxford BioDynamics Stock Down 22.7 %

The company has a current ratio of 0.68, a quick ratio of 2.80 and a debt-to-equity ratio of 370.22. The business’s fifty day moving average price is GBX 1.82 and its 200 day moving average price is GBX 5.11. The company has a market capitalization of £5.30 million, a P/E ratio of -36.67 and a beta of 0.42.

Insider Buying and Selling

In related news, insider David Holbrook purchased 49,653 shares of the stock in a transaction on Monday, October 28th. The shares were purchased at an average cost of GBX 1 ($0.01) per share, for a total transaction of £496.53 ($629.16). Company insiders own 16.78% of the company’s stock.

About Oxford BioDynamics

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.